Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil versus fentanyl for long-term postoperative sleep quality
ACTRN12610000362099Phase 4Not yet recruiting
- Sponsor
- Manuel Wenk
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remifentanil and fentanyl in sleep disorder (2 arms), sponsored by Manuel Wenk. Primary endpoint: Changes in postoperative quality of sleep. Planned start May 2010; status: not yet recruiting.
02
Drugs
remifentanilfentanyl
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ACTRN12610000362099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000362099.